Skip to Content


Test Helps Predict Chemotherapy Response

Conquest - Fall 2011

Could Guide Treatment for Breast Cancer Patients

W. Fraser Symmans, 

Researchers have developed a new test to predict which patients with newly diagnosed breast cancer have excellent probability of response and survival following chemotherapy.

Using an algorithm combining genomic information from the biopsy of a patient’s tumor, the test identified those for whom standard therapy had high probability of success, as well as those who might benefit from participating in a clinical trial.

“The research builds on a decade of collaborative work in developing a clinically meaningful chemotherapy predictor,” says W. Fraser Symmans, M.D., professor in 
MD Anderson’s Department of Pathology.

“If validated in future studies, it could guide therapy for about 80% of newly diagnosed women with invasive breast cancer who are candidates for chemotherapy,”

Reported in the May 11, 2011, issue of the Journal of the American Medical Association.

Care to Comment?

Email the editor to comment on a story or offer suggestions on topics you'd like to see covered in future issues of Conquest and Annual Report.

Make a difference

Your gift to MD Anderson makes a difference in the lives of cancer patients by supporting innovative patient care, research, education and prevention programs. You can Donate Now or learn more at myGiving to MD Anderson.

© 2015 The University of Texas MD Anderson Cancer Center